Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by Lee430on Jul 13, 2022 4:03pm
77 Views
Post# 34821996

RE:Sent to ir

RE:Sent to ir Has anyone seen an indication of improved retail engagement since Elif McDonald has taken the IR reins?

Bucknelly21 wrote: Good afternoon elif, clearly today was a significant event for those who follow thera closely, very positive and a big boost. I would also like to point out that the market reaction or lack there of, should really be a great indication that thera past interaction/strategies in dealing with capital markets has severely failed, hence the non reaction. As per our last conversation this is why i feel its so important to have more promotion of the stock in the market. Today’s reaction makes it very obvious that not many are paying attention, any other company with a decent following that was informed would have made some significant appreciation in the stock price. I will be honest at the end of the day it really feels that shareholder’s and the stock are far down on the priority list for the company its been year after years of milestones coming and going as well as awful to no coverage. As an investor it gets exhausting seeing significant events get little to no reward for my DD simply because the company doesnt do something that is so easy as building a bit of excitement and a bigger retail base. Hopefully there is a plan in place to change this.


<< Previous
Bullboard Posts
Next >>